Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pandemic and All-Hazards Preparedness Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: ARNOLD & PORTER KAYE SCHOLER LLP
H.R. 5533: Biodefense Pandemic Vaccine & Drug Development Act of 2006 S. 3678: Pandemic & All-Hazards Preparedness Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2026 · second_quarter · Q2
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2026 · first_quarter · Q1
Source: Senate LDA
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2025 · fourth_quarter · Q4
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2025 · third_quarter · Q3
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2025 · second_quarter · Q2
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2025 · first_quarter · Q1
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2024 · fourth_quarter · Q4
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2024 · third_quarter · Q3
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2024 · second_quarter · Q2
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2024 · first_quarter · Q1
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2023 · fourth_quarter · Q4
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2023 · third_quarter · Q3
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2023 · second_quarter · Q2
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2023 · first_quarter · Q1
Issues related to various healthcare reform and drug pricing.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2022 · fourth_quarter · Q4
Issues related to various healthcare reform and drug pricing proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2022 · third_quarter · Q3
Issues related to various healthcare reform and drug pricing proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2022 · second_quarter · Q2
Issues related to various healthcare reform and drug pricing proposals.
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2022 · first_quarter · Q1
Issues related to various healthcare reform and drug pricing proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · fourth_quarter · Q4
Issues related to various healthcare reform and drug pricing proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · third_quarter · Q3
Issues related to various healthcare reform and drug pricing proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · second_quarter · Q2
Issues related to various healthcare reform and drug pricing proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2021 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2020 · first_quarter · Q1
Issues related to various health care reform proposals.
Filing targets: Health & Human Services, Dept of (HHS)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2019 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2018 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2018 · third_quarter · Q3
Issues related to various health care reform proposals.
Filing targets: SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2018 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2018 · first_quarter · Q1
Issues related to various health care reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2017 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2017 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2017 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2017 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2016 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2016 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2016 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2016 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2015 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2015 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2015 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2015 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2014 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2014 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2014 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2014 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2013 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2013 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2013 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2013 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2012 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2012 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2012 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2012 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2011 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2011 · third_quarter · Q3
Issues related to various health care reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2011 · second_quarter · Q2
Issues related to various health care reform proposals.
Filing targets: Internal Revenue Service (IRS)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2011 · first_quarter · Q1
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2010 · fourth_quarter · Q4
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2010 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2010 · second_quarter · Q2
Issues related to various health care reform proposals.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2010 · first_quarter · Q1
Issues related to various health care reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2009 · fourth_quarter · Q4
Issues related to various health care reform proposals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2009 · third_quarter · Q3
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2009 · second_quarter · Q2
Issues related to various health care reform proposals.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2008 · third_quarter · Q3
Researched alternatives to potential pharmaceutical legislation.
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2008 · first_quarter · 1A
Issues related to the DOD Authorizatuion Act for 2008 Issues related to the Deficit Reduction Act of 2005
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2008 · first_quarter · Q1
Prepare for and participate in meeting regarding the Deficit Reduction Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2007 · year_end · YY
Issues related to the DOD Authorization Act for 2008 Issues related to the Deficit Reduction Act of 2005
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) via ARNOLD & PORTER KAYE SCHOLER LLP
2007 · mid_year · RA
Issues related to the 2008 Department of Defense Authorization Act and the Deficit Reduction Act of 2005.
BIOTECHNOLOGY INDUSTRY ORGANIZATION via ARNOLD & PORTER KAYE SCHOLER LLP
2006 · year_end · YY
H.R. 5533: Biodefense Pandemic Vaccine & Drug Development Act of 2006 S. 3678: Pandemic & All-Hazards Preparedness Act
Filing targets: Health & Human Services, Dept of (HHS), SENATE